stock ticker hero image

Investor relations

Our science-led strategy is key to delivering long-term value for patients, employees and shareholders.

NYSE: MRK
August 8, 2020 6:44 pm ET
Delayed at least 20 minutes

View stock information

Latest news, events & financials

Our pipeline shows our relentless pursuit of the next breakthrough.

Phase II programs
12
Phase III programs
21
Under review
2
Merck leadership team at investor event

Our leadership

Our deep bench of talent has the knowledge, commitment and expertise to successfully execute on our innovation strategy.

women harvesting tea leaves with basket

Corporate responsibility

Supporting the future of our business and the health and well-being of patients, people and communities around the world.

Explore our CR report

Download ESG Progress Report

We're led by our science

We follow the science to our next breakthrough, leaving no stone unturned.

View our stories

2Q 2020 Financial results

Merck announced second-quarter worldwide sales of $10.9 billion – a decrease of 8% compared with the second quarter of 2019 – reflecting the negative impact of COVID-19. Excluding the impact from foreign exchange, sales declined 5%. ​ The company anticipates full-year 2020 revenue range to be between $47.2 billion and $48.7 billion, including a negative […]

Read more

Next: 2Q 2020 Financial results

Merck announces three significant scientific efforts in the fight against COVID-19

COVID-19 continues to be an extraordinary challenge to the global community. As a company dedicated to saving and improving lives for more than 100 years, we have a special responsibility to help in the fight against COVID-19. Merck has been fully committed to developing an effective response to the COVID-19 pandemic since it was first […]

Read more

Next: Merck announces three significant scientific efforts in the fight against COVID-19

No patient left behind in our clinical trials

We’re here for patients when they need us most

Read more

Next: No patient left behind in our clinical trials

Merck joins South San Francisco biotech community with innovative research site and hunger for collaboration

The site sits at the center of an important biotechnology hub Decades before it became a hive of biotechnology activity, South San Francisco was a hotspot for manufacturing technologies. In 1943, our company tapped into the city’s workforce and resources, and moved into the neighborhood after buying a milk of magnesium manufacturing facility on East […]

Read more

Next: Merck joins South San Francisco biotech community with innovative research site and hunger for collaboration

Previous
Next

Unsubscribe from email alerts

Contact us banner image
For questions, please contact our team.

Contact investor relations